Answers are grounded in this paper and cite their sources.
In renal transplant patients maintenance therapy with low dose tacrolimus and mycophenolate mofetil in combination is used to prevent renal injury and graft rejection. 1On the other hand, calcineurin inhibitors can lead to chronic renal damage characterized by progressive and irreversible deterioration of renal function associated with interstitial fibrosis, tubular atrophy, arteriolar hyalinosis, and glomerulosclerosis in about 1% of patients. 2Individual factors increase susceptibility to calcineurin-inhibitor related renal injury (CIRRI), such as expression of the metabolizing cytochrome P450 3A5 (CYP3A5) in kidneys although the pathogenesis of CIRRI is far from being fully understood. 3opical calcineurin inhibitors are approved for the treatment of atopic dermatitis.Whole blood concentrations of the lipophilic drug tacrolimus have been < 3 ng/ml in clinical trials. 4opical tacrolimus has also been used off-label to treat pyoderma gangrenosum successfully, either as monotherapy or in combination with systemic immunosuppressive regimes. 7No renal adverse effects have been reported so far.A 50-year-old male patient with mutilocal pyoderma gangrenosum of the lower legs since 2008 was treated by methylprednisolone 40 mg/d, enteric mycophenlate mofetil (MFF) 760 mg twice daily, pantoprazole 20 mg/d, and topical tacrolimus ointment 0.1% for the inflammatory borders of the wounds.His medical history was remarkable for bone tuberculosis that was treated by rifampicin and isonicotinic acid hydracide (INH) until January 2012.Because of severe back pain he was taking hydromorphon (Jurnista) 16 mg/d, morphin (Sevredol) 20 mg 2x1, and metamizole (Novalgin) 3x30 gtt/d.Laboratory controls demonstrated an increase of serum creatinine since late January.He became somnolent and was brought to the local hospital.
No takes yet. Share an insight, caveat, or question.
Uwe Wollina (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: